This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Title: Elyse Bourque: Innovator in Pharmaceutical Research
Introduction
Elyse Bourque is a notable inventor based in L'Étang-Du Nord, Canada. She has made significant contributions to the field of pharmaceutical research, particularly in the development of treatments for respiratory viruses.
Latest Patents
Elyse Bourque holds a patent for "Bicyclic Fused Pyrazole Derivatives For The Treatment Of RSV." This patent discloses compounds of Formula lb, or pharmaceutically acceptable salts thereof, and compositions for treating or inhibiting RSV and related members of the pneumovirus and paramyxovirus families. These include human metapneumovirus, mumps virus, human parainfluenza viruses, and Nipah and Hendra virus, along with methods of treatment or prevention thereof. She currently has 0 patents.
Career Highlights
Elyse Bourque is associated with Vaxart, Inc., a company focused on innovative vaccine development. Her work is pivotal in advancing therapeutic options for viral infections.
Collaborations
Elyse collaborates with esteemed colleagues such as Richard K. Plemper and Eddy Lee, contributing to a dynamic research environment that fosters innovation.
Conclusion
Elyse Bourque's work in pharmaceutical research exemplifies her commitment to developing effective treatments for viral infections. Her contributions are vital in the ongoing battle against respiratory viruses.